👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

AstraZeneca, commodity-linked shares drag London's FTSE 100 down

Published 23/10/2023, 08:21
© Reuters. FILE PHOTO: Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File photo
UK100
-
BARC
-
GC
-
SI
-
FTMC
-
INDV
-

By Khushi Singh and Bansari Mayur Kamdar

(Reuters) -Britain's FTSE 100 closed at its lowest level in nearly seven weeks on Monday, hurt by a sell-off in heavyweight AstraZeneca (NASDAQ:AZN) and commodity-linked stocks.

The FTSE 100 dipped 0.4%, while the mid-cap FTSE 250 rose 0.2%, outpacing its commodity-focused peer.

Oil major BP (LON:BP) shed 2.4% as crude prices fell over 1% on easing fears about potential supply disruptions as diplomatic efforts in the Middle East intensified.

Drugmaker AstraZeneca fell 3.2%.

"AstraZeneca is also acting as a drag even as CEO Pascal Soriot hits back at reports he is to step down, describing them as 'fake news'," said Michael Hewson, chief market analyst at CMC Markets UK, in a note.

Leading sectoral losses, precious metal miners shed 3.2% as gold prices weakened after U.S. 10-year Treasury yields briefly hit 5% before retreating.

Industrial metal miners eased 1.2% tracking softer copper prices as sentiment was hit by China's property crisis, dwindling hopes of stronger stimulus measures in the world's top consumer of industrial metals, and the conflict in the Middle East.

"People are considering a slowdown in economic output and the potential for recession does weigh on commodities," said Danni Hewson, head of financial analysis at AJ Bell.

Homebuilder Vistry tempered its annual profit forecast and said it would cut about 200 jobs as part of a restructuring, taking the shares down 5.8% to the bottom of the FTSE 250.

"It is the undermining consumer confidence that people are putting off moving and buying a home especially if they're a first-time buyer," added Hewson

Keller Group (LON:KLR) jumped 16.5%, leading gains on the mid-cap index after the engineering contractor said it expects its annual operating profit to be materially ahead of market expectations.

© Reuters. FILE PHOTO: Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File photo

Indivior added 5.2% after the drugmaker said it would pay $385 million to settle a lawsuit.

Meanwhile, ratings agency Moody's revised Britain's outlook to "stable" from "negative" on Friday, saying policy predictability has been restored after heightened volatility last year.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.